Interacting Drugs |
Aluminum hydroxide, magnesium hydroxide, and simethicone vs Mesalamine |
Security Level |
|
Mechanism |
Mesalamine: Antacids may diminish the therapeutic effect of Mesalamine. Antacid-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products. |
Management |
Avoid concurrent administration of antacids with sustained-release mesalamine products. Separating antacid and mesalamine administration, and/or using lower antacid doses may be adequate means of avoiding this interaction. |
Aluminum hydroxide, magnesium hydroxide, and simethicone vs Mesalamine
Post Review about Aluminum hydroxide, magnesium hydroxide, and simethicone vs Mesalamine Click here to cancel reply.
Other Interactions of Aluminum hydroxide, magnesium hydroxide, and simethicone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.